|
AU2014200256A1
|
|
Diabetes-related biomarkers and methods of use thereof
|
|
TW201217788A
|
|
Method for determining risk of diabetes
|
|
EP2494364A1
|
|
Protein and lipid biomarkers providing consistent improvement to the prediction of type 2 diabetes
|
|
EP2494483A2
|
|
Method for determining risk of diabetes
|
|
US2009271124A1
|
|
Diabetes-related biomarkers and methods of use thereof
|
|
WO2009137606A1
|
|
Methods for use with nanoreactors
|
|
CA2686039A1
|
|
Binding reagents that contain small epitope binding molecules
|
|
TW200849035A
|
|
Diabetes-related biomarkers and methods of use thereof
|
|
EP2030025A2
|
|
Markers associated with arteriovascular events and methods of use thereof
|
|
EP2407562A1
|
|
Systems and methods for developing diagnostic tests based on biomarker information from legacy clinical sample sets
|
|
CA2645159A1
|
|
Multiplex protein fractionation
|
|
WO2007092433A2
|
|
Osteoporosis associated markers and methods of use thereof
|
|
US2007218519A1
|
|
Diabetes-associated markers and methods of use thereof
|
|
AU2004267802A1
|
|
Methods for reducing complexity of a sample using small epitope antibodies
|
|
AU2003215083A8
|
|
Method and apparatus for validating dna sequences without sequencing
|
